We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cyclerion Therapeutics Inc | NASDAQ:CYCN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.96 | 1.12 | 4.00 | 2.88 | 2.88 | 2.88 | 154 | 05:00:05 |
Massachusetts |
001-38787
|
83-1895370
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
Common Stock, no par value
|
CYCN
|
|
Item 3.03 |
Material Modification to Rights of Security Holders.
|
Item 5.03 |
Amendment to Articles of Incorporation or Bylaws.
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|||||||||||||
Errol De Souza, Ph.D.
|
24,043,739
|
482,205
|
95,703
|
7,829,214
|
||||||||||||
Peter M. Hecht, Ph.D.
|
22,832,872
|
1,729,771
|
59,004
|
7,829,214
|
||||||||||||
Steven Hyman, M.D.
|
24,124,609
|
418,935
|
78,103
|
7,829,214
|
||||||||||||
Ole Isacson, M.D., Ph.D.
|
24,121,645
|
409,714
|
90,288
|
7,829,214
|
||||||||||||
Terrance McGuire
|
18,940,792
|
5,607,350
|
73,505
|
7,829,214
|
For
|
Against
|
Abstain
|
||
32,100,837
|
309,269
|
40,755
|
For
|
Against
|
Abstain
|
||
29,493,422
|
2,912,129
|
45,310
|
Item 7.01 |
Regulation FD Disclosure.
|
Item 8.01 |
Other Events.
|
Item 9.01 |
Financial Statements and Exhibits.
|
Exhibit No.
|
Description
|
Articles of Amendment to the Restated Articles of Organization of the Company.
|
|
Press Release dated May 15, 2023.
|
|
104
|
Cover Page Interactive Data File
|
Cyclerion Therapeutics, Inc.
|
||||
Dated: May 15, 2023
|
By:
|
/s/ Anjeza Gjino
|
||
Name:
|
Anjeza Gjino
|
|||
Title:
|
Chief Financial Officer
|
1 Year Cyclerion Therapeutics Chart |
1 Month Cyclerion Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions